Cargando…

Incidence of Cytomegalovirus disease and viral replication kinetics in seropositive liver transplant recipients managed under preemptive therapy in a tertiary-care center in Mexico City: a retrospective cohort study

BACKGROUND: In the absence of an adequate prevention strategy, up to 20% of CMV IgG+ liver transplant recipients (LTR) will develop CMV disease. Despite improved reporting in CMV-DNAemia, there is no consensus as to what the ideal CMV-DNAemia cutoff for a successful preemptive strategy is. Each tran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-García, Oscar A., García-Juárez, Ignacio, Belaunzarán-Zamudio, Pablo Francisco, Vilatoba, Mario, Wisniowski-Yáñez, Andrea, Salomón-Ávila, Jacobo, Bobadilla-del-Valle, Miriam, Sifuentes-Osornio, José, Cuellar-Rodríguez, Jennifer M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845382/ https://www.ncbi.nlm.nih.gov/pubmed/35164684 http://dx.doi.org/10.1186/s12879-022-07123-w

Ejemplares similares

1748. Incidence of Cytomegalovirus Disease and Viral Replication Kinetics in Intermediate Risk Liver Transplant Recipients Managed According to a Preemtive Therapy Algortihm
por: Fernández, Oscar, et al.
Publicado: (2019)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
por: Kim, Jong Man, et al.
Publicado: (2015)

Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy
por: Atabani, S F, et al.
Publicado: (2012)

Transition from antigenemia to quantitative nucleic acid amplification testing in cytomegalovirus-seropositive kidney transplant recipients receiving preemptive therapy for cytomegalovirus infection
por: Nakamura, Mônica Rika, et al.
Publicado: (2022)

Perioperative Comparison of Preemptive and Non-Preemptive Renal Transplant Recipients
por: Aytekin, Sami, et al.
Publicado: (2020)

Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy
por: Kim, Tark, et al.
Publicado: (2016)

Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk
por: VELİOĞLU, Arzu, et al.
Publicado: (2022)

Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation
por: Papazian, Laurent, et al.
Publicado: (2021)

LB21. Preemptive Therapy (PET) vs. Prophylaxis for Prevention of Cytomegalovirus (CMV) Disease in High-Risk Donor Seropositive/Recipient Seronegative (D+R−) Liver Transplant Recipients (LTR): A NIH-Sponsored, Randomized, Controlled, Multicenter Trial
por: Singh, Nina, et al.
Publicado: (2018)

Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
por: Lodding, I P, et al.
Publicado: (2018)

Importance of the cytomegalovirus seropositive recipient as a contributor to disease burden after solid organ transplantation
por: Emery, Vincent C., et al.
Publicado: (2012)

Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management
por: Blom, Kjersti B., et al.
Publicado: (2023)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2017)

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
por: Restelli, Umberto, et al.
Publicado: (2019)

Seropositivity of cytomegalovirus in patients with recurrent pregnancy loss
por: Sherkat, Roya, et al.
Publicado: (2014)

2079. The Relation Between Panel Reactive Antibody Assay and Cytomegalovirus Reactivation in Seropositive Solid Organ Transplantation Recipients
por: Kwon, Da Eun, et al.
Publicado: (2018)

Risk factors for cytomegalovirus disease in seropositive renal transplant recipients; a single-center case-controlled study
por: Navarro-Rodríguez, Viviana, et al.
Publicado: (2017)

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
por: Ljungman, Per, et al.
Publicado: (2020)

Risk factors associated with prolonged hospital length-of-stay: 18-year retrospective study of hospitalizations in a tertiary healthcare center in Mexico
por: Marfil-Garza, Braulio A., et al.
Publicado: (2018)

Mo1358: IMPACT OF SARS-COV-2 INFECTION ON RECIPIENTS OF LIVER TRANSPLANT. REPORT OF A MEXICAN COHORT.
por: Azamar-Llamas, Daniel, et al.
Publicado: (2022)

Symptomatic Congenital Cytomegalovirus Infection in Children of Seropositive Women
por: Mack, Ines, et al.
Publicado: (2017)

Cytomegalovirus Seropositivity and Suicidal Behavior: A Mini-Review
por: Paolini, Marco, et al.
Publicado: (2019)

Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients
por: Navarro, David, et al.
Publicado: (2016)

Increased Inflammatory Response in Cytomegalovirus Seropositive Patients with Alzheimer’s Disease
por: Westman, Gabriel, et al.
Publicado: (2014)

Human cytomegalovirus seropositivity is associated with decreased survival in glioblastoma patients
por: Foster, Haidn, et al.
Publicado: (2019)

A Mortality Analysis of the Cytomegalovirus (CMV) Infection Letermovir Prophylaxis Trial in CMV-Seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation (HCT)
por: Maertens, Johan, et al.
Publicado: (2017)

782. Risk Factors, Clinical Characteristic, and Treatment Outcomes for Nontuberculous Mycobacterial Disease in Mexico
por: Luis, Bruno Ali Lopez, et al.
Publicado: (2018)

Comparison of preemptive kidney transplant recipients with nonpreemptive kidney recipients in single center: 5 years of follow-up
por: Sayin, Burak, et al.
Publicado: (2013)

Predictive Factors of Cytomegalovirus Seropositivity among Pregnant Women in Paris, France
por: N’Diaye, Dieynaba S., et al.
Publicado: (2014)

Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients
por: Rauwel, B., et al.
Publicado: (2020)

Cytomegalovirus shedding in seropositive healthy women of reproductive age in Tianjin, China
por: Ju, D., et al.
Publicado: (2020)

Human cytomegalovirus seropositivity is associated with reduced patient survival during sepsis
por: Unterberg, M., et al.
Publicado: (2023)

Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
por: McBride, Jacqueline M, et al.
Publicado: (2019)

Human tuberculosis caused by Mycobacterium bovis: a retrospective comparison with Mycobacterium tuberculosis in a Mexican tertiary care centre, 2000–2015
por: Torres-Gonzalez, Pedro, et al.
Publicado: (2016)

Local evidence on the cytomegalovirus viral load threshold for preemptive treatment is welcome, and a comment on indirect effects
por: Requião-Moura, Lúcio R.
Publicado: (2021)

Antiviral prophylaxis or preemptive therapy for cytomegalovirus after liver transplantation?: A systematic review and meta-analysis
por: Yadav, Dipesh Kumar, et al.
Publicado: (2022)

Cytomegalovirus infections in the blood recipient.
por: Nankervis, G. A.
Publicado: (1976)

Cytomegalovirus infection in transplant recipients
por: Azevedo*, Luiz Sergio, et al.
Publicado: (2015)

Repeated measures study of weekly and daily cytomegalovirus shedding patterns in saliva and urine of healthy cytomegalovirus-seropositive children
por: Cannon, Michael J, et al.
Publicado: (2014)

Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure
por: Ordaz-Vázquez, Anabel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_949i8km9tr0vl0uu2qqq6rm0u0